Corporate Banner
Satellite Banner
Biologics & Bioprocessing
Scientific Community
 
Become a Member | Sign in
Home>Events>This Event
  Events - July 2014


How to automate the analysis of MS data for biotherapeutics characterization

15 Jul 2014 - 15 Jul 2014 - Webinar



Bookmark and Share


Tuesday, July 15, 2:30 PM - 3:30 PM BST
Register for this webinar

As the use of mass spectrometry (MS) to characterize biotherapeutics increases throughout the entire discovery and development process, organizations are being deluged with data and are struggling to find new ways to automate data processing, analysis, and reporting. The fact that MS laboratories often employ instruments from a variety of vendors, each with its own data processing software, contributes significantly to the difficulty in streamlining and automating analysis and reporting. To address this data analysis bottleneck, there is a clear need for vendor agnostic software that can standardize and automate data processing of MS data from any source. In this live webinar, use cases on improving the characterization of biotherapeutics using Genedata Expressionist software will be presented. This will include: 

Intact protein analysis
Peptide mapping
Glycopeptide analysis
Disulphide bond analysis
Sequence variant analysis 

WHO SHOULD ATTEND
Bioanalytical scientists who are characterizing biopharmaceuticals using Mass Spectrometry 

SPEAKER
Joe Shambaugh, Scientific Consultant, Genedata Inc. 



Further information
Scientific News
Mass Spec Technology Drives Innovation Across the Biopharma Workflow
With greater resolving power, analytical speed, and accuracy, new mass spectrometry technology and techniques are infiltrating the biopharmaceuticals workflow.
Biomolecular Manufacturing ‘On-the-Go’
Wyss Institute team unveils a low-cost, portable method to manufacture biomolecules for a wide range of vaccines, other therapies as well as diagnostics.
Molecular Switch Aids Immune Therapy
Researchers identify strategy to maximise effectiveness of immune therapy through molecular switch controlling immune suppression.
Novavax RSV F Vaccine Fails Phase 3 Trial
Novavax announces topline RSV F Vaccine data from two clinical trials in older adults.
GSK’s Shingles Vaccine Candidate Shows High Efficacy
The vaccine candidate showed high efficacy against shingles and its complications in adults aged 70yrs+ in phase III study.
Eisai Establishes AiM Institute
The Andover innovative Medicines (AiM) Institute will develop innovative precision medicines for hard-to-treat conditions.
Antibodies that Target Holes in HIV's Defence Identified
Scientists suggest 'holes' in HIV sugar sheild can be targeted by antibodies.
Discovery Could Yield Improved Flu Vaccines
Researchers have discovered a type of immune antibody that can evolve to combat a number of infuenza virus strains.
First Accurate Simulation of a Virus Invading a Cell
For the first time, scientists know what happens to a virus’ shape when it invades a host cell.Understanding how the virus shape specifically changes could lead to more effective anti-viral therapies.
Developing a Vaccine for Sexually Transmitted and Insect-Borne Zika Infections
Prokarium announce the beginning of a programme to develop an oral vaccine against Zika infection.
Scroll Up
Scroll Down
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,000+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!